Decoding Toll-like receptors: Recent insights and perspectives in innate immunity

T Kawai, M Ikegawa, D Ori, S Akira - Immunity, 2024 - cell.com
Toll-like receptors (TLRs) are an evolutionarily conserved family in the innate immune
system and are the first line of host defense against microbial pathogens by recognizing …

Current status and outlook for ATRP

K Matyjaszewski - European Polymer Journal, 2024 - Elsevier
Atom transfer radical polymerization (ATRP) is one of the most often used controlled radical
polymerization techniques. It employs very small amounts (ppm) of Cu complexes in the …

Radiation-Activated Resiquimod Prodrug Nanomaterials for Enhancing Immune Checkpoint Inhibitor Therapy

J Sun, H Yao, X Ren, L Cui, L Liu, G Wang, Z Tang - Nano Letters, 2024 - ACS Publications
Immune checkpoint inhibitor (ICI) therapy is effectively employed in treating various
malignancies. However, the response rate is constrained to 5–30%, which is attributed to …

[HTML][HTML] Thiol-triggered deconstruction of bifunctional silyl ether terpolymers via an SN Ar-triggered cascade

CM Brown, KEL Husted, Y Wang, LJ Kilgallon… - Chemical …, 2023 - pubs.rsc.org
While Si-containing polymers can often be deconstructed using chemical triggers such as
fluoride, acids, and bases, they are resistant to cleavage by mild reagents such as biological …

Smart chemistry for traceless release of anticancer therapeutics

CJ Prange, X Hu, L Tang - Biomaterials, 2023 - Elsevier
In the design of delivery strategies for anticancer therapeutics, the controlled release of
intact cargo at the destined tumor and metastasis locations is of particular importance. To …

[HTML][HTML] Polymeric nanocapsules loaded with poly (I: C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors

C Anfray, CF Varela, A Ummarino, A Maeda… - Frontiers in …, 2024 - frontiersin.org
Background In the tumor microenvironment (TME), tumor-associated macrophages (TAMs)
play a key immunosuppressive role that limits the ability of the immune system to fight …

Molecular masking of synthetic Immunomodulator evokes antitumor immunity with reduced immune tolerance and systemic toxicity by temporal activity recovery and …

HS Shin, S Kim, SM Jin, YJ Yoo, JH Heo… - Advanced …, 2024 - Wiley Online Library
Activation of the innate immune system counteracts tumor‐induced immunosuppression.
Hence, small molecule‐based toll‐like receptor 7/8 agonists (TLR7/8a), which can modulate …

[HTML][HTML] Recent developments in synthetic approaches for macromolecular prodrugs

J Alex, C Weber, C Guerrero-Sanchez… - Progress in Polymer …, 2024 - Elsevier
In the last decades, nanoscale drug delivery systems have gained great attention partly due
to their ability to improve the bioavailability of water insoluble drugs. To this end, the general …

[HTML][HTML] Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines

K Song, SH Pun - BME frontiers, 2024 - spj.science.org
With the recent advances in neoantigen identification, peptide-based cancer vaccines offer
substantial potential in the field of immunotherapy. However, rapid clearance, low …

Harnessing biomaterial architecture to drive anticancer innate immunity

MA Davis, E Cho, MH Teplensky - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Immunomodulation is a powerful therapeutic approach that harnesses the body's own
immune system and reprograms it to treat diseases, such as cancer. Innate immunity is key …